Zydus Lifesciences Limited's market cap is currently ₹905.81B. The company's EPS TTM is ₹45.028; its P/E ratio is 19.99; and it has a dividend yield of 0.33%. Zydus Lifesciences Limited is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ₹11.23. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 195.47B	₹ 168.78B	₹ 148.28B	₹ 148.22B	₹ 138.12B
Gross Profit	₹ 89.25B	₹ 105.68B	₹ 90.09B	₹ 93.42B	₹ 86.63B
Operating Income	₹ 45.40B	₹ 28.53B	₹ 24.74B	₹ 27.36B	₹ 21.02B
EBITDA	₹ 56.22B	₹ 34.42B	₹ 36.71B	₹ 32.33B	₹ 25.25B
Net Income	₹ 38.59B	₹ 19.60B	₹ 44.87B	₹ 21.34B	₹ 11.77B
Balance Sheet
Cash & Short-Term Investments	₹ 13.58B	₹ 14.20B	₹ 35.05B	₹ 11.27B	₹ 13.40B
Total Assets	₹ 292.81B	₹ 257.56B	₹ 277.95B	₹ 238.85B	₹ 236.87B
Total Debt	₹ 8.04B	₹ 11.95B	₹ 42.21B	₹ 46.08B	₹ 80.14B
Net Debt	₹ 3.91B	₹ 7.07B	₹ 35.63B	₹ 39.42B	₹ 71.69B
Total Liabilities	₹ 71.79B	₹ 60.68B	₹ 87.42B	₹ 89.55B	₹ 119.76B
Stockholders' Equity	₹ 198.29B	₹ 175.16B	₹ 170.00B	₹ 129.92B	₹ 103.76B
Cash Flow
Free Cash Flow	₹ 23.21B	₹ 16.58B	₹ 9.02B	₹ 24.39B	₹ 16.01B
Operating Cash Flow	₹ 32.28B	₹ 26.89B	₹ 21.04B	₹ 32.93B	₹ 25.05B
Investing Cash Flow	₹ -14.75B	₹ 11.71B	₹ 11.54B	₹ -7.22B	₹ -10.12B
Financing Cash Flow	₹ -18.10B	₹ -44.00B	₹ -8.68B	₹ -25.49B	₹ -10.94B

Currency in INR

Zydus Lifesciences Limited Earnings and Revenue History

Income Statement >

Zydus Lifesciences Limited Debt to Assets

Balance Sheet >

Zydus Lifesciences Limited Cash Flow

Cash Flow >

Zydus Lifesciences Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing